Treatment with PKF 115–584, a small-molecule antagonist of the Tcf/β-catenin complex, decreased the amount of total MMP-9 approximately 75% in epithelial cells and 85% in stromal cells in patients with endometriosis [4]. This evidence concerns the gene MMP9 and endometriosis.